Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chkl binds and phosphorylates BAD protein.
Han EK, Butler C, Zhang H, Severin JM, Qin W, Holzman TF, Gubbins EJ, Simmer RL, Rosenberg S, Giranda VL, Ng SC, Luo Y. Han EK, et al. Anticancer Res. 2004 Nov-Dec;24(6):3907-10. Anticancer Res. 2004. PMID: 15736430 Free article.
Fluorescent microplate assay for cancer cell-associated cathepsin B.
Hulkower KI, Butler CC, Linebaugh BE, Klaus JL, Keppler D, Giranda VL, Sloane BF. Hulkower KI, et al. Among authors: butler cc. Eur J Biochem. 2000 Jul;267(13):4165-70. doi: 10.1046/j.1432-1327.2000.01458.x. Eur J Biochem. 2000. PMID: 10866820 Free article.
Species specificity of amidine-based urokinase inhibitors.
Klinghofer V, Stewart K, McGonigal T, Smith R, Sarthy A, Nienaber V, Butler C, Dorwin S, Richardson P, Weitzberg M, Wendt M, Rockway T, Zhao X, Hulkower KI, Giranda VL. Klinghofer V, et al. Biochemistry. 2001 Aug 7;40(31):9125-31. doi: 10.1021/bi010186u. Biochemistry. 2001. PMID: 11478879
d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial.
Hayward G, Mort S, Hay AD, Moore M, Thomas NPB, Cook J, Robinson J, Williams N, Maeder N, Edeson R, Franssen M, Grabey J, Glogowska M, Yang Y, Allen J, Butler CC. Hayward G, et al. Among authors: butler cc. JAMA Intern Med. 2024 Apr 8:e240264. doi: 10.1001/jamainternmed.2024.0264. Online ahead of print. JAMA Intern Med. 2024. PMID: 38587819 Free PMC article.
Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.
Dorward J, Sookrajh Y, Lessells R, Bulo E, Bodley N, Singh L, Moodley P, Samsunder N, Drain PK, Hayward G, Butler CC, Garrett N. Dorward J, et al. Among authors: butler cc. J Acquir Immune Defic Syndr. 2024 Apr 15;95(5):e8-e11. doi: 10.1097/QAI.0000000000003385. Epub 2024 Mar 11. J Acquir Immune Defic Syndr. 2024. PMID: 38489494 Free PMC article.
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
Hayward G, Yu LM, Little P, Gbinigie O, Shanyinde M, Harris V, Dorward J, Saville BR, Berry N, Evans PH, Thomas NPB, Patel MG, Richards D, Hecke OV, Detry MA, Saunders C, Fitzgerald M, Robinson J, Latimer-Bell C, Allen J, Ogburn E, Grabey J, de Lusignan S, Hobbs FR, Butler CC; PRINCIPLE Trial Collaborative Group. Hayward G, et al. Among authors: butler cc. J Infect. 2024 Apr;88(4):106130. doi: 10.1016/j.jinf.2024.106130. Epub 2024 Feb 29. J Infect. 2024. PMID: 38431155 Free PMC article. Clinical Trial.
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.
Png ME, Harris V, Grabey J, Hart ND, Jani BD, Butler D, Carson-Stevens A, Coates M, Cureton L, Dobson M, Dorward J, Evans P, Francis N, Gbinigie OA, Hayward G, Holmes J, Hood K, Khoo S, Ahmed H, Lown M, Mckenna M, Mort S, Nguyen-Van-Tam J, Rahman N, Richards DB, Thomas N, van Hecke O, Hobbs FR, Little P, Yu LM, Butler CC, Petrou S. Png ME, et al. Among authors: butler cc. Br J Gen Pract. 2024 Jan 16:BJGP.2023.0444. doi: 10.3399/BJGP.2023.0444. Online ahead of print. Br J Gen Pract. 2024. PMID: 38228357
391 results